ReviewDer Nervenarzt2025
[How extended reality applications make a difference in psychotherapy].
Review in Der Nervenarzt, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExtended reality (XR) encompasses various immersive technologies that enhance perception with virtual elements. Previous research has focused in particular on virtual reality-assisted exposure therapy but there are currently dynamic developments in terms of both content and structure of XR research for psychotherapy.
methodsThis narrative review describes content-related, technical and structural developments in the research of XR applications for psychotherapy, as identified by members of the Extended Reality for Psychotherapy network.
resultsThe use of mixed reality technologies and artificial intelligence was mentioned as well as the development and testing of creative therapeutic concepts beyond the classical exposure paradigm. In addition, structural developments, such as the establishment of standardized processes, the professionalization of development, barriers to implementation in healthcare practice and regulatory aspects are outlined. DISCUSSION: The experts point to technical advances and emerging innovative concepts that would not be feasible in the current psychotherapy. Given the complex technology, which must simultaneously meet multiple regulatory requirements, broad-based interdisciplinary research is needed.
Indexed as
Identifiers
41296285What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.